Recruiting Interstitial Lung Disease Studies in Burlington
About Interstitial Lung Disease Clinical Trials in Burlington
Interstitial lung disease is a group of disorders characterized by progressive scarring of lung tissue, leading to breathlessness and reduced oxygen exchange. Causes include autoimmune diseases, environmental exposures, and unknown factors. Treatment includes antifibrotic medications and immunosuppressants.
There are currently 1 interstitial lung disease clinical trials recruiting participants in Burlington, NC. These studies are seeking a combined 240 participants. Research is being sponsored by University of Vermont. Clinical trial participation is free and participants receive study-related medical care at no cost.
Interstitial Lung Disease Clinical Trials in Burlington — FAQ
Are there interstitial lung disease clinical trials in Burlington?
Yes, there are 1 interstitial lung disease clinical trials currently recruiting in Burlington, NC. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Burlington?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Burlington research site will contact you about next steps.
Are clinical trials in Burlington free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Burlington studies also compensate for your time and travel.
What interstitial lung disease treatments are being tested?
The 1 active trials in Burlington are testing new therapies including novel drugs, biologics, and treatment approaches for interstitial lung disease.
Data updated July 13, 2026 from ClinicalTrials.gov